SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TOSHI

TOSHI.X is trending as the community anticipates potential exchange listings and discusses recent price action, including overcoming resistance levels and dropping a zero. Many community members express excitement and encourage others to buy and hold, while some caution against potential volatility. Talk centers around TOSHI potentially becoming a leading meme coin on the Base network.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending following an analyst upgrade from UBS and anticipation surrounding NIO Day, with the launch of the new ES8 model. The community is focused on the company's potential to capture a larger share of the EV market and whether the stock can sustain its recent upward momentum, potentially leading to a short squeeze. Some are drawing comparisons to other EV companies while awaiting key catalysts in the coming days.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as chatter revolves around expansion plans, particularly in the US with the opening of new stores in NYC, and potential franchise opportunities. Community members are discussing its growth relative to competitors like Starbucks and Dutch Bros, especially given China's growing coffee market. Some investors speculate about a potential relisting and the impact of a Starbucks China sale.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending as community members discuss potential government contracts and recent large volume. Some traders are pointing to a congresswoman's stock purchase and Goldman Sachs increasing its position as bullish signals, while others highlight the company's AI technology and government ties. Community members are speculating on possible catalysts and price movements for the stock.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending as part of a broader quantum computing sector rally, with community members discussing its potential to follow the gains of peers like IONQ. Some traders are pointing to potential resistance levels and anticipating a dip, while others suggest a short squeeze is imminent amid the overall sector momentum. Options activity and historical price movements are also being closely watched.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining ($CIFR) is trending as investors speculate on a potential deal with a major hyperscaler for its AI data center capacity, similar to recent deals in the sector. Community members are actively discussing entry points, options strategies given the high implied volatility, and comparing $CIFR to peers like $WULF and $IREN. Bullish sentiment is fueled by analysts raising price targets and the belief that the company is undervalued given its infrastructure and potential in the AI space.

Tidal Trust II - YieldMax MSTR Option Income Strategy ETF

YieldMax MSTR Option Income Strategy ETF

MSTY is trending as investors discuss its correlation with MSTR and Bitcoin, focusing on potential gains from Bitcoin's rise. Community members are weighing the ETF's high yield against concerns about NAV erosion and debating whether to buy, hold, or sell. The potential inclusion of MSTR in the S&P 500 is also driving conversation, with some anticipating a positive impact on MSTY.

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Dynavax Technologies Corp.

Dynavax (DVAX) is trending due to community discussion around its valuation, upcoming ACIP meeting, and recent Phase 1/2 shingles vaccine data. Community members are debating the impact of a Goldman Sachs downgrade and potential management changes. Some express frustration with the stock's performance, while others remain optimistic about its pipeline and potential in the healthcare sector.

Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks the treatment of neurocognitive disorders and degeneration, specifically attention deficit hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is trending as traders discuss its potential for another volatile run, drawing comparisons to its previous dramatic surge. Community members are pointing to its low float and high insider ownership as potential catalysts, while some caution about the stock's fundamentals. Discussions also involve identifying other stocks that could emulate RGC's past performance.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Kura Oncology is trending due to anticipation surrounding upcoming data releases for its lead drug candidate, ziftomenib, particularly its potential in treating AML. Community discussions revolve around recent trial data, the company's financial position, and speculation about a potential buyout, with some expressing concerns over past dilution. Bullish sentiment is fueled by insider buying, positive analyst ratings, and the drug's potential for accelerated FDA approval.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Windtree Therapeutics Inc. drew increased retail chatter on Tuesday after disclosing plans to adopt a cryptocurrency policy that would enable it to accept digital currencies as payment and hold them as assets.The stock closed at $0.79, up 5% on Tuesday, but declined 4.9% to $0.75 in after-hours trading.The biotech firm said its board approved the development of the policy, which aims to align with broader digital commerce trends.&nbsp;The move comes as the company pursues a transition toward a revenue-generating model.Windtree added that it is in discussions with several groups that focus on Bitcoin and other cryptocurrencies as potential payment options.&nbsp;The company also said it may hold long-term digital assets as part of a broader treasury strategy.On Stocktwits, retail sentiment was ‘neutral’ amid ‘high’ message volume.One user noted increased buying interest in Windtree, citing low float and crypto-related news.&nbsp;<stembedurl>https://stocktwits.com/makedatbread88/message/616696047</stembedurl>Meanwhile, another user expressed skepticism, saying they had never seen a stock that consistently declines.<stembedurl>https://stocktwits.com/Lord_Andrew_London/message/616705134</stembedurl>The stock has declined 95.4% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representation of Bitcoin, Ripple, Litecoin and Ethereum cryptocurrencies is seen in this illustration photo taken in Krakow, Poland on June 6, 2021. (Photo Illustration by Jakub Porzycki/NurPhoto via Getty Images)

Windtree Stock Falls After-Hours As Board Approves Crypto Policy Amid Revenue Diversification Efforts

The company plans to accept and hold cryptocurrencies and is in talks with several groups focused on digital payments.

Equity

Why Windtree Therapeutics (WINT) Stock Is Volatile Today

Windtree Therapeutics shares are trading lower by 8.6% during Monday's session. The company announced it entered a $1M private placement.
read more...

What's Going On With Windtree Therapeutics Stock?

Windtree Therapeutics shares are racing higher Friday after the company requested the withdrawal of its Registration Statement previously filed with the SEC.
read more...

U.S. stocks rose on Friday morning as investors digested the latest inflation data, which reinforced expectations of a September interest rate cut. The broader market exhibited a mixed performance in the previous session, with early optimism stemming from strong GDP data fading as tech giants dragged down the Nasdaq and S&amp;P 500.Here’s a look at the top three stocks that captured retail investors’ attention ahead of the opening bell today:Windtree Therapeutics Inc (WINT)<figure class="image"><a href="https://stocktwits.com/symbol/WINT"><img style="aspect-ratio:1316/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/WINT_sentiment_and_message_volume_score_on_Jul_26_58f5cea25d.png" alt="WINT sentiment and message volume score on Jul 26.png" width="1316" height="320"></a><figcaption>WINT sentiment and message volume score premarket on Jul 26</figcaption></figure>Shares of Windtree Therapeutics surged by an impressive 150% in pre-market trading to reach a high $9.40. The biopharma company announced an update on its novel heart failure treatment, istaroxime, igniting a buying frenzy among retail investors.&nbsp;Stocktwits data revealed overwhelmingly bullish sentiment (71/100), with message volume reaching its highest level this year (90/100). While the stock has experienced a significant decline of over 73% year-to-date, today's surge has injected a dose of optimism among investors.Dexcom Inc (DXCM)In stark contrast to Windtree's performance, Dexcom Inc witnessed a dramatic decline of over 36% in pre-market trading, settling in the mid $60s. The medical device company's disappointing second-quarter revenue results and a weak FY24 revenue guidance for its glucose monitoring devices triggered a sell-off. Despite the price drop, several analysts maintained price targets well above current levels, suggesting potential upside in the long term.&nbsp;However, retail investor sentiment on Stocktwits plummeted to its lowest point this year (10/100), reflecting the bearish outlook, while message volumes reached a 2024 peak (96/100). Concerns about management’s inability to adequately communicate business issues and its plan to fix it, as well as market share impacts from the adoption of GLP-1 weight loss drugs is keeping retail away. &nbsp;<figure class="image"><a href="https://stocktwits.com/symbol/DXCM"><img style="aspect-ratio:1324/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/DXCM_sentiment_and_message_volume_score_on_Jul_26_17d563e160.png" alt="DXCM sentiment and message volume score on Jul 26.png" width="1324" height="314"></a><figcaption>DXCM sentiment and message volume score premarket on Jul 26</figcaption></figure>Anavex Life Sciences Corporation (AVXL)Shares of Anavex Life Sciences Corporation climbed over 4% in pre-market trading to a high of $7.22, with retail sentiment on Stocktwits at bullish levels (65/100).&nbsp;The neuro-disease-focused biopharma company received a boost from EF Hutton analyst Jason Kolbert, who initiated coverage with a Buy rating and a price target of $46. The analyst highlighted the company's lead therapy, ANAVEX2-73, for Alzheimer's Disease (AD), which is on track for regulatory submission by the end of the year. The potential market for ANAVEX2-73, coupled with its broader therapeutic applications, has fueled investor optimism.<figure class="image"><a href="https://stocktwits.com/symbol/AVXL"><img style="aspect-ratio:1320/312;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/AVXL_sentiment_and_message_volume_score_on_Jul_26_d22a8e0bab.png" alt="AVXL sentiment and message volume score on Jul 26.png" width="1320" height="312"></a><figcaption>AVXL sentiment and message volume score premarket on Jul 26</figcaption></figure><a href="https://www.vecteezy.com/photo/29286690-ai-generative-business-man-standing-in-the-stock-market-realistic-image-ultra-hd-high-design-very-detailed">Photo</a> courtesy of syedqaseem on Vecteezy

WINT Soars, DXCM Plunges, AVXL Gains: Retail Investors' Focus Before the Bell

Two stocks are sparking optimism on Stocktwits with watchers passionately discussing potential catalysts, while one is losing a lot of favor following its disappointing earnings and outlook. 

WINT Soars, DXCM Plunges, AVXL Gains: Retail Investors' Focus Premarket

12 titres de soins de sant  en mouvement lors de la session apr s-cl ture le 08/04/2024

Gagnants
L'action Kineta (NASDAQ:KA) a mont lundi de 16,77% 0,63 dollars lors de la session after-market.
Le titre Windtree Therapeutics (NASDAQ:WINT) a mont de 14,63% 0,47 dollars.
Le titre...

Windtree Therapeutics, Inc. (NASDAQ:WINT) Short Interest Down 56.0% in February

Windtree Therapeutics, Inc. (NASDAQ:WINT  Get Free Report) was the recipient of a significant decrease in short interest in February. As of February 15th, there was short interest totalling...

Windtree Therapeutics, Inc. (NASDAQ:WINT) Sees Large Decline in Short Interest

Windtree Therapeutics, Inc. (NASDAQ:WINT  Get Free Report) saw a large decrease in short interest in the month of February. As of February 15th, there was short interest totalling 101,100...

Windtree Therapeutics files to sell 608,272 shares of common stock for holders

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Windtree Therapeutics   This Biotech Inks License Deal For Lead Candidate

Craig Fraser, CEO of Windtree Therapeutics, Inc. (NASDAQ: WINT), was recently interviewed by Benzinga.
Windtree is advancing late-stage interventions for cardiovascular disorders to treat patients in...

Windtree Therapeutics (NASDAQ:WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company

WARRINGTON, PA / ACCESSWIRE / January 26, 2024 / Windtree Therapeutics (NASDAQ:WINT) announced an agreement with affiliates of biopharma investor Deerfield Management Company to fully retire a $15...

Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company engaged in the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. It focuses on the treatment of acute cardiovascular and acute pulmonary diseases. It's portfolio of product candidates includes istaroxime, a Phase II candidate with SERCA2a activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure and preclinical precision aPKCi inhibitors that are being developed for potential in rare and broad oncology applications. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.

Windtree Therapeutics Inc

Cut 25 bps

Cut 50+ bps

No change

Hike 25 bps

It’s Fed Decision Week. Polymarket gives a 90% chance of a 25 bps cut. What’s your call? 
 
*Powered by Polymarket

WINT
Windtree Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Latest WINT News

WINT Windtree Therapeutics Inc